We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$5.97B
Cap. Flow %
-2.34%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$311M
2
EXR icon
Extra Space Storage
EXR
+$293M
3
KO icon
Coca-Cola
KO
+$246M
4
TCO
Taubman Centers Inc.
TCO
+$211M
5
NTAP icon
NetApp
NTAP
+$188M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.77%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AST
3976
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$6K ﹤0.01%
+1,239
New +$11.9K
JMBA
3977
DELISTED
Jamba, Inc.
JMBA
$6K ﹤0.01%
398
+16
+4% +$252
FENX
3978
DELISTED
Fenix Parts, Inc.
FENX
$6K ﹤0.01%
+571
New +$5.96K
RKUS
3979
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$6K ﹤0.01%
605
-443
-42% -$5.08K
AMPH icon
3980
Amphastar Pharmaceuticals
AMPH
$899M
$5K ﹤0.01%
+307
New +$4.79K
ARDX icon
3981
Ardelyx
ARDX
$1.25B
$5K ﹤0.01%
+327
New +$4.12K
ARWR icon
3982
Arrowhead Research
ARWR
$12.3B
$5K ﹤0.01%
+741
New +$5.09K
ATRA icon
3983
Atara Biotherapeutics
ATRA
$73.6M
$5K ﹤0.01%
+4
New +$4.59K
AXDX
3984
DELISTED
Accelerate Diagnostics
AXDX
$5K ﹤0.01%
+20
New +$4.78K
BCRX icon
3985
BioCryst Pharmaceuticals
BCRX
$2.35B
$5K ﹤0.01%
+362
New +$4.12K
BPMC
3986
DELISTED
Blueprint Medicines
BPMC
$5K ﹤0.01%
+177
New +$5.05K
CDTX
3987
DELISTED
Cidara Therapeutics
CDTX
$5K ﹤0.01%
+18
New +$5.54K
CERS icon
3988
Cerus
CERS
$579M
$5K ﹤0.01%
+983
New +$4.66K
CRDF icon
3989
Cardiff Oncology
CRDF
$66.2M
$5K ﹤0.01%
+7
New +$4.96K
DRRX
3990
DELISTED
DURECT Corp
DRRX
$5K ﹤0.01%
+222
New +$5.22K
ELDN icon
3991
Eledon Pharmaceuticals
ELDN
$263M
$5K ﹤0.01%
+2
New +$3.87K
EXEL icon
3992
Exelixis
EXEL
$14.1B
$5K ﹤0.01%
1,368
-2,215
-62% -$7.2K
IMUX icon
3993
Immunic
IMUX
$191M
$5K ﹤0.01%
+1
New +$9.54K
INO icon
3994
Inovio Pharmaceuticals
INO
$54M
$5K ﹤0.01%
+51
New +$5.45K
INSM icon
3995
Insmed
INSM
$22B
$5K ﹤0.01%
+225
New +$5.11K
INVA icon
3996
Innoviva
INVA
$1.57B
$5K ﹤0.01%
277
-798,900
-100% -$13.7M
IOVA icon
3997
Iovance Biotherapeutics
IOVA
$2.09B
$5K ﹤0.01%
+569
New +$6.35K
KALV
3998
DELISTED
KalVista Pharmaceuticals
KALV
$5K ﹤0.01%
+54
New +$5.36K
KPTI icon
3999
Karyopharm Therapeutics
KPTI
$159M
$5K ﹤0.01%
+13
New +$5.62K
LCTX icon
4000
Lineage Cell Therapeutics
LCTX
$277M
$5K ﹤0.01%
+1,643
New +$6.37K

Similar funds

Invesco's Q2 2015 Portfolio in Review

As of Q2 2015, Invesco held 4,482 positions worth $255B, down 1.4% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Invesco's Q2 2015 filing shows 462 new, 1,845 increased, 1,866 reduced and 145 closed positions. Its largest new stake was Anthem, Inc.: 1,170,000 shares worth $61.6M. The largest sale was Fiat Chrysler Automobiles N.V., an estimated $3.11B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2015 buy was Anthem, Inc.: 1,170,000 shares worth $61.6M.
  • Invesco added most to Equinix in Q2 2015, an estimated $311M increase.
  • Invesco's biggest Q2 2015 reduction was Fiat Chrysler Automobiles N.V., cutting an estimated $3.11B.
  • Invesco fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $126M.
  • Invesco's ten largest holdings make up 13% of its $255B portfolio in Q2 2015.
  • Invesco opened 462 new positions and closed 145 in Q2 2015.
  • Invesco's portfolio value fell 1.4% quarter-over-quarter to $255B.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.